Brian Claggett

Near-universal prevalence of central adiposity in heart failure with preserved ejection fraction: the PARAGON-HF trial

Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy

Finerenone Reduces New-Onset Atrial Fibrillation Across the Spectrum of Cardio-Kidney-Metabolic Syndrome

Initial Decline in Glomerular Filtration Rate With Finerenone in HFmrEF/HFpEF

Adiposity-Related Anthropometrics and Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction

Finerenone and new-onset diabetes in heart failure: a prespecified analysis of the FINEARTS-HF trial

Finerenone and Atrial Fibrillation in Heart Failure

EuroQol 5-Dimension Questionnaire in Heart Failure With Reduced, Mildly Reduced, and Preserved Ejection Fraction

Effects of Finerenone on Natriuretic Peptide Levels in Heart Failure with Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF Trial

Finerenone in Heart Failure With Improved Ejection Fraction

The Efficacy of Finerenone on Hierarchical Composite Endpoint Analysed Using Win Statistics in Patients with Heart Failure and Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of FINEARTS-HF

Anthropometric Measures, Cardiovascular Outcomes, and Treatment Effects of Finerenone in Cardiovascular-Kidney-Metabolic Disease

A Nationwide Factorial Randomized Trial of Electronic Nudges to Patients With Chronic Kidney Disease and Their General Practices for Increasing Guideline-Directed Medical Therapy: The NUDGE-CKD Trial

Cardiovascular-Focused Messaging to Improve Influenza Vaccination Rates

Severe Heart Failure and Treatment With Dapagliflozin Across the Ejection Fraction Spectrum

Efficacy and Tolerability of Finerenone According to the Use and Dosage of Diuretics

Finerenone and NYHA Functional Class in Heart Failure

Re-Evaluating Recurrent Events in Heart Failure Trials

Digital Nudges to Increase Influenza Vaccination in Patients with Chronic Diseases

Pulmonary Congestion on Lung Ultrasound in Ambulatory Patients With Heart Failure With Preserved Ejection Fraction

Electronic nudges to increase influenza vaccination uptake in younger and middle-aged individuals with atrial fibrillation: a prespecified analysis of the NUDGE-FLU-CHRONIC trial

Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis

Finerenone in heart failure and chronic kidney disease with type 2 diabetes: FINE-HEART pooled analysis of cardiovascular, kidney and mortality outcomes

Finerenone and Kidney Outcomes in Patients With Heart Failure

Effect of Aficamten on Cardiac Structure and Function in Obstructive Hypertrophic Cardiomyopathy

Cardiovascular Burden of the V142I Transthyretin Variant

Finerenone, Obesity, and Heart Failure With Mildly Reduced/Preserved Ejection Fraction

Prognostic Models for Mortality and Morbidity in Heart Failure With Preserved Ejection Fraction

Finerenone in Patients With a Recent Worsening Heart Failure Event

Cardiovascular-Kidney-Metabolic Overlap in Heart Failure With Mildly Reduced or Preserved Ejection Fraction